Literature DB >> 16385253

Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation.

Robert C De Lisle1, Eileen A Roach, Oxana Norkina.   

Abstract

OBJECTIVES: Mucus accumulation in cystic fibrosis (CF) is involved in blockage of the distal small intestine. Because expression of mucin genes and mucus secretion can be increased by infection and previous work indicated that small intestinal bacterial overgrowth occurs in CF, we tested whether reduction of bacterial load by antibiotic treatment would reduce mucin gene expression and mucus accumulation in the CF mouse small intestine.
METHODS: CF transmembrane conductance regulator null (cftr (tm1UNC)) and wild type littermates were treated with ciprofloxacin and metronidazole for 3 weeks. Muc2 and Muc3 gene expression were measured by quantitative reverse-transcriptase polymerase chain reaction. Periodic acid Schiff (PAS) staining and morphometry were used to measure the size of mucus droplets within goblet cells and dilation of the intestinal crypt lumen, as estimates of mucus secretion and accumulation.
RESULTS: Antibiotic treatment did not significantly affect Muc2 and Muc3 gene expression in CF mice. In untreated CF mice, the crypt lumen was almost sevenfold wider than wild type. Antibiotic treatment of CF mice reduced the intensity of PAS crypt lumen staining, and the lumen width was decreased by approximately 25%. The area occupied by PAS-positive material in goblet cells was significantly greater in tissues from antibiotic treated mice.
CONCLUSIONS: Eradication of bacterial overgrowth in CF mice significantly decreased mucus secretion and accumulation in intestinal crypts without an effect on mucin gene expression. It is proposed that bacterial overgrowth stimulates mucus secretion, which contributes to its accumulation in the small intestine. Control of bacterial overgrowth is expected to reduce mucus accumulation and may improve intestinal function and overall health in CF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16385253     DOI: 10.1097/01.mpg.0000189322.34582.3e

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  13 in total

1.  Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis.

Authors:  Marjan Wouthuyzen-Bakker; Marcel J C Bijvelds; Hugo R de Jonge; Robert C De Lisle; Johannes G M Burgerhof; Henkjan J Verkade
Journal:  Pediatr Res       Date:  2012-01       Impact factor: 3.756

Review 2.  Patterns of GI disease in adulthood associated with mutations in the CFTR gene.

Authors:  Michael Wilschanski; Peter R Durie
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

3.  Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches.

Authors:  Anna Ermund; André Schütte; Malin E V Johansson; Jenny K Gustafsson; Gunnar C Hansson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-05       Impact factor: 4.052

4.  Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse.

Authors:  Robert C De Lisle; Racquel Mueller; Megan Boyd
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-10       Impact factor: 2.839

5.  Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype.

Authors:  Robert C De Lisle; Racquel Mueller; Eileen Roach
Journal:  BMC Gastroenterol       Date:  2010-09-15       Impact factor: 3.067

Review 6.  The gastrointestinal mucus system in health and disease.

Authors:  Malin E V Johansson; Henrik Sjövall; Gunnar C Hansson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-12       Impact factor: 46.802

7.  Disrupted tight junctions in the small intestine of cystic fibrosis mice.

Authors:  Robert C De Lisle
Journal:  Cell Tissue Res       Date:  2013-10-30       Impact factor: 5.249

8.  Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice.

Authors:  Emily M Bradford; Maureen A Sartor; Lara R Gawenis; Lane L Clarke; Gary E Shull
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-22       Impact factor: 4.052

Review 9.  The cystic fibrosis intestine.

Authors:  Robert C De Lisle; Drucy Borowitz
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

10.  Goblet cell hyperplasia is not epithelial-autonomous in the Cftr knockout intestine.

Authors:  Nancy M Walker; Jinghua Liu; Sarah M Young; Rowena A Woode; Lane L Clarke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-12-08       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.